These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8268857)

  • 21. Effects of 1,25-dihydroxicolecalciferol and dietary calcium-phosphate on distribution of lead to tissues during growth.
    Cortina-Ramírez GE; Cerbón-Solorzano J; Calderón-Salinas JV
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):123-7. PubMed ID: 16223518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined therapy with calcitonin and high doses of active vitamin D3 metabolites in uremic hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Puka J; Sawicki A; Switalski M; Tałałaj M; Pacocha E; Marusza W; Ostrowski K
    Pol Arch Med Wewn; 1996 Jul; 96(1):23-31. PubMed ID: 8966142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA; Beneton M; Harvey L; Lawson DE
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of 1,25-dihydroxyvitamin D
    Nishikawa M; Yasuda K; Takamatsu M; Abe K; Nakagawa K; Tsugawa N; Hirota Y; Tanaka K; Yamashita S; Ikushiro S; Suda T; Okano T; Sakaki T
    J Steroid Biochem Mol Biol; 2019 Jan; 185():71-79. PubMed ID: 30031146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
    Burnatowska-Hledin MA; Doyle TM; Eadie MJ; Mayor GH
    J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dietary calcium restriction on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules.
    Langman CB; Favus MJ; Bushinsky DA; Coe FL
    J Lab Clin Med; 1985 Sep; 106(3):286-92. PubMed ID: 2993458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 1 alpha(OH)-vitamin D3 and 24,25(OH)2-vitamin D3 on long bones of glucocorticoid-treated rats.
    Turnquist J; Ornoy A; Eini D; Schwartz Z
    Acta Anat (Basel); 1992; 145(1):61-7. PubMed ID: 1414214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of eel calcitonin derivative (elcatonin) in osteoporosis].
    Yoshikawa S; Shiba M; Hoshino T; Igarashi M; Orimo H; Sakuma A; Tsuyama N
    Nihon Seikeigeka Gakkai Zasshi; 1983 Nov; 57(11):1717-28. PubMed ID: 6676389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat.
    Hughes MR; Baylink DJ; Gonnerman WA; Toverud SU; Ramp WK; Haussler MR
    Endocrinology; 1977 Mar; 100(3):799-806. PubMed ID: 233823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat.
    Favus MJ; Mangelsdorf DJ; Tembe V; Coe BJ; Haussler MR
    J Clin Invest; 1988 Jul; 82(1):218-24. PubMed ID: 2839546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1 alpha-Hydroxylated cholecalciferol compounds act additively with microbial phytase to improve phosphorus, zinc and manganese utilization in chicks fed soy-based diets.
    Biehl RR; Baker DH; DeLuca HF
    J Nutr; 1995 Sep; 125(9):2407-16. PubMed ID: 7666260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF; Hermey DC; Popoff SN; Seifert MF
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High vitamin D and calcium intakes increase bone mineral (Ca and P) content in high-fat diet-induced obese mice.
    Song Q; Sergeev IN
    Nutr Res; 2015 Feb; 35(2):146-54. PubMed ID: 25530010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development-related regulation of plasma 1,25(OH)2D3 concentration by calcium intake in rat pups.
    Clark SA; Boass A; Toverud SU
    Bone Miner; 1986 Jun; 1(3):193-203. PubMed ID: 3508725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronopharmacology of oxacalcitriol in rat model of osteoporosis.
    Tsuruoka S; Wakaumi M; Yamamoto H; Fujimura A
    Eur J Pharmacol; 2004 Mar; 488(1-3):239-45. PubMed ID: 15044057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.